Xin Lang Cai Jing·2025-09-11 02:22Group 1 - The core viewpoint of the news is that Yipinhong Pharmaceutical Group experienced a decline in stock price, with a drop of 5.41% to 58.10 CNY per share, and a total market capitalization of 26.243 billion CNY [1] - Yipinhong's main business involves the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals, with revenue composition being 61.12% from children's medicine, 22.71% from chronic disease medicine, and 16.17% from other products [1] Group 2 - From the perspective of fund holdings, one fund under CITIC Jiantou has Yipinhong as its top holding, with 95,000 shares, accounting for 0.91% of the fund's net value [2] - The CITIC Jiantou Yuanjian Return A fund has a current scale of 430 million CNY and has achieved a year-to-date return of 28.48%, ranking 2387 out of 8175 in its category [2] - The fund manager, Xie Wei, has a tenure of 7 years and 101 days, with the best fund return during his tenure being 114.91% [2]